A 58-year-old patient with type 2 diabetes mellitus presents with an HbA1c level of 9.2%, elevated serum creatinine, microalbuminuria, and non-proliferative diabetic retinopathy. Which nursing intervention is most critical to prioritize in the care plan to prevent further complications?

D) Initiating insulin therapy under physician guidance

A) Scheduling regular ophthalmologic examinations

B) Collaborating with a dietitian for nutritional counseling

C) Educating the patient on the importance of blood pressure control

D) Initiating insulin therapy under physician guidance

A patient with type 2 diabetes presents with an HbA1c of 9.2%, elevated serum creatinine of 1.4 mg/dL, and microalbuminuria with a urinary albumin-to-creatinine ratio of 45 mg/g. The patient is also diagnosed with non-proliferative diabetic retinopathy. Which of the following nursing interventions should be prioritized to address the patient's condition?

B) Educate the patient on the importance of adhering to a low-sodium, low-fat diet.

A) Encourage the patient to increase fluid intake to support renal function.

B) Educate the patient on the importance of adhering to a low-sodium, low-fat diet.

C) Advise the patient to take over-the-counter eye vitamins to improve vision.

D) Instruct the patient to monitor blood glucose levels more frequently.

A patient with type 2 diabetes presents with signs of mild peripheral neuropathy and has difficulty adhering to their medication regimen. The healthcare team decides to initiate basal insulin therapy and enroll the patient in a diabetes education program. Which of the following interventions would be most effective in preventing further complications and improving the patient's overall health outcomes?

C) Reinforcing the importance of medication adherence and scheduling regular follow-ups for monitoring and support.

A) Emphasizing the importance of daily blood glucose monitoring and adjusting insulin doses independently.

B) Providing detailed dietary plans focusing on low carbohydrate intake without further nutritional guidance.

C) Reinforcing the importance of medication adherence and scheduling regular follow-ups for monitoring and support.

D) Encouraging increased physical activity without consideration of the patient's current physical capacity and neuropathy symptoms.

A patient with type 2 diabetes is starting a basal insulin regimen due to inadequate glycemic control on oral medications. The patient also exhibits mild peripheral neuropathy and has a diet high in processed foods. Which nursing intervention is most essential to prioritize during the initial phase of insulin therapy?

B) Teach the patient how to recognize and manage signs of hypoglycemia.

A) Educate the patient on the importance of foot care to prevent complications from peripheral neuropathy.

B) Teach the patient how to recognize and manage signs of hypoglycemia.

C) Develop a meal plan with the patient that reduces intake of processed foods.

D) Monitor the patient's blood pressure closely to assess the effectiveness of antihypertensive therapy.

A patient with type 2 diabetes presents with moderate, persistent pain in the lower extremities and evidence of decreased vibratory sensation in the feet. Recent lab results show an elevated HbA1c and an increased LDL cholesterol level. Which nursing intervention is most appropriate to address these findings and improve the patient's condition?

B) Educate the patient on the importance of adhering strictly to their statin and insulin therapy regimen.

A) Advise the patient to increase their physical activity to at least 150 minutes of moderate-intensity exercise per week.

B) Educate the patient on the importance of adhering strictly to their statin and insulin therapy regimen.

C) Suggest the patient reduce their carbohydrate intake significantly to lower blood glucose levels quickly.

D) Recommend the patient begin a daily routine of foot care and inspection to prevent further neuropathic complications.

A patient with type 2 diabetes is experiencing moderate, persistent pain in the lower extremities. Upon examination, decreased vibratory sensation in the feet and diminished Achilles reflexes are noted. The patient is also found to have an elevated HbA1c level of 8.5% and a lipid profile showing an LDL cholesterol level of 130 mg/dL. Which nursing intervention is most appropriate to address the patient's current symptoms and lab findings?

B) Educate the patient on the importance of adhering to a low-sodium, low-fat diet and initiate gabapentin therapy for neuropathic pain.

A) Increase the patient's insulin dose to improve glycemic control and reduce neuropathy symptoms.

B) Educate the patient on the importance of adhering to a low-sodium, low-fat diet and initiate gabapentin therapy for neuropathic pain.

C) Suggest the addition of an ACE inhibitor to the treatment plan to manage hypertension and protect kidney function.

D) Reinforce statin therapy adherence to lower LDL cholesterol and recommend increased physical activity to enhance circulation.

A patient with type 2 diabetes and hypertension presents with slightly elevated blood pressure and modest improvement in HbA1c after recent interventions. However, the patient’s renal function tests show a decrease in eGFR and an increase in serum creatinine. Which nursing intervention is most appropriate to prioritize in this scenario?

D) Coordinate a nephrology referral for further evaluation.

B) Suggest adding a calcium channel blocker to the antihypertensive regimen.

C) Recommend a dietary consultation to further reduce sodium intake.

D) Coordinate a nephrology referral for further evaluation.

A patient with type 2 diabetes mellitus is being followed up for diabetic complications. Despite adherence to gabapentin, the patient reports intermittent neuropathic pain. The blood pressure remains slightly elevated at 142/88 mmHg, and recent lab results indicate a modest reduction in HbA1c to 8.2%, a slight decrease in LDL cholesterol to 124 mg/dL, and a concerning rise in serum creatinine to 1.3 mg/dL with eGFR at 55 mL/min/1.73m². Which intervention should the nurse prioritize to address the patient's current complications and prevent further damage?

C) Consult with a nephrologist to evaluate renal function and adjust hypertension treatment.

A) Increase the dose of gabapentin to better manage neuropathic pain.

B) Intensify dietary modifications to further improve glycemic control.

C) Consult with a nephrologist to evaluate renal function and adjust hypertension treatment.

D) Add a beta-blocker to further control blood pressure and reduce cardiovascular risk.

A patient with diabetic neuropathy and nephropathy presents with pedal edema, dizziness, and fatigue. Given the patient's current symptoms and lab results, which nursing intervention is most appropriate to address the potential fluid retention and optimize blood pressure control?

B) Educate the patient on reducing sodium intake to decrease fluid retention.

A) Encourage the patient to increase fluid intake to promote renal function.

B) Educate the patient on reducing sodium intake to decrease fluid retention.

C) Suggest the patient limit physical activity to reduce fatigue.

D) Advise the patient to increase carbohydrate intake for energy.

A 65-year-old patient with diabetic nephropathy is experiencing persistent neuropathy and newly reported dizziness and fatigue, particularly in the mornings. Laboratory results show a decline in renal function and the presence of microalbuminuria. The healthcare team is considering adjusting the patient's antihypertensive regimen. What is the most appropriate nursing intervention to prioritize in managing this patient's current condition?

B) Instruct the patient to monitor blood pressure at home and report any significant changes.

A) Educate the patient on the importance of increasing fluid intake to manage dizziness.

B) Instruct the patient to monitor blood pressure at home and report any significant changes.

C) Advise the patient to decrease protein intake to protect renal function.

D) Encourage the patient to engage in daily exercise to improve overall health.

T2DM - Nursing Case Study

Pathophysiology

• Primary mechanism: Insulin resistance - In type 2 diabetes mellitus (T2DM), the body's cells become less responsive to insulin, a hormone that facilitates glucose uptake into cells. This resistance forces the pancreas to produce more insulin to maintain normal blood glucose levels, eventually leading to pancreatic beta-cell dysfunction.

• Secondary mechanism: Impaired insulin secretion - Over time, the pancreas's beta cells, which produce insulin, become dysfunctional due to chronic overwork. This results in inadequate insulin production, further exacerbating hyperglycemia.

• Key complication: Hyperglycemia - The combined effects of insulin resistance and impaired insulin secretion cause elevated blood glucose levels, leading to long-term vascular and organ damage, increasing the risk for complications like cardiovascular disease, neuropathy, and retinopathy.

Patient Profile

Demographics:

55-year-old male, office manager

History:

• Key past medical history: Diagnosed with Type 2 Diabetes Mellitus 8 years ago, hypertension, hyperlipidemia

• Current medications: Metformin 1000 mg twice daily, Lisinopril 20 mg once daily, Atorvastatin 20 mg once daily, Aspirin 81 mg once daily

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increasing fatigue and numbness in feet

• Key symptoms: Blurred vision, frequent urination, increased thirst, tingling in extremities, occasional dizziness

• Vital signs: Blood pressure 145/90 mmHg, heart rate 88 bpm, respiratory rate 18 breaths per minute, temperature 98.6°F, BMI 31 kg/m²

Section 1

During a follow-up appointment, the patient's laboratory results reveal an HbA1c level of 9.2%, indicating poor glycemic control over the past three months. Additionally, serum creatinine levels are elevated at 1.4 mg/dL (normal range: 0.6-1.2 mg/dL), suggesting potential early-stage renal impairment. Microalbuminuria is also detected, with urinary albumin-to-creatinine ratio (UACR) measuring 45 mg/g (normal: <30 mg/g), pointing towards diabetic nephropathy. These findings are particularly concerning given the patient's history of hypertension and hyperlipidemia, which further increase the risk for cardiovascular and renal complications.

The patient reports that his blurred vision has worsened, prompting a referral to an ophthalmologist for a comprehensive eye examination. The ophthalmologist identifies signs of non-proliferative diabetic retinopathy, characterized by microaneurysms and retinal hemorrhages. This development underscores the need for stricter blood sugar management and regular ophthalmologic monitoring to prevent progression to vision-threatening stages.

In response to these findings, the healthcare team initiates a multidisciplinary approach to address the patient's deteriorating condition. The primary care provider discusses the possibility of starting insulin therapy to achieve better glycemic control, while the patient is also referred to a dietitian for nutritional counseling. Emphasis is placed on lifestyle modifications such as increased physical activity and dietary changes to aid in weight management. The patient is encouraged to adhere to a low-sodium, low-fat diet to support cardiovascular and renal health. These interventions aim to mitigate the risk of further complications and provide a comprehensive management plan tailored to the patient's needs.

Section 2

As the patient embarks on the new management regimen, an initial assessment is conducted to evaluate both the immediate and potential long-term impact of these interventions. The patient's vital signs reveal a blood pressure of 145/90 mmHg, indicating that despite antihypertensive therapy, tighter control is necessary. The heart rate stands at 78 beats per minute, and the patient's weight is recorded at 92 kg with a BMI of 31, classifying him as obese. A thorough review of the patient's current medication adherence reveals occasional lapses in taking antihypertensive and statin medications, highlighting the need for reinforced education on the importance of medication compliance.

During the physical examination, the patient reports mild peripheral neuropathy symptoms, such as tingling and numbness in the feet, which have been more pronounced over the past few weeks. This finding suggests the progression of diabetic neuropathy, necessitating further evaluation and possible adjustment of pharmacologic therapies to manage neuropathic pain and prevent further nerve damage. Additionally, the patient's dietary recall indicates a diet high in processed foods and low in fresh fruits and vegetables, leading to recommendations for more substantial dietary modifications with the guidance of the dietitian.

Given these assessments, the healthcare team decides to intensify the patient's diabetes management plan. The initiation of insulin therapy is confirmed, starting with a basal insulin regimen to stabilize blood glucose levels. The patient is also enrolled in a diabetes education program to enhance self-management skills, focusing on blood glucose monitoring, recognition of hypoglycemia, and the importance of lifestyle changes. Follow-up appointments are scheduled bi-weekly to closely monitor progress and make necessary adjustments to the therapeutic plan. By targeting these areas, the team aims to prevent the escalation of diabetic complications and support the patient in achieving better overall health outcomes.

Section 3

Two weeks into the intensified diabetes management plan, the patient returns for a follow-up appointment. The healthcare team notes that while the patient has been diligent in attending diabetes education sessions, there are early signs of new complications requiring immediate attention. The patient reports moderate, persistent pain in the lower extremities, which is now affecting daily activities and sleep quality. Upon examination, there is evidence of decreased vibratory sensation in the feet and diminished Achilles reflexes, confirming the advancement of diabetic neuropathy. The healthcare team considers incorporating a medication like gabapentin to address the neuropathic pain while continuing to monitor the efficacy of the basal insulin regimen.

Additionally, recent lab results reveal a concerning trend: the patient's HbA1c level remains elevated at 8.5%, indicating insufficient glycemic control despite the initiation of insulin therapy. The patient's lipid profile also shows an LDL cholesterol level of 130 mg/dL, higher than the target level for patients with type 2 diabetes, suggesting the need for reinforcement of statin therapy adherence and possibly adjusting the dosage. The renal function test results show a slight increase in serum creatinine and a decrease in eGFR, hinting at early diabetic nephropathy. This finding prompts the team to consider adding an ACE inhibitor to the treatment plan, which can help protect kidney function and manage hypertension more effectively.

The healthcare team decides to prioritize dietary modifications, emphasizing a low-sodium and low-fat diet, and increase the frequency of blood glucose monitoring to identify patterns and triggers for hyperglycemia. The patient is encouraged to keep a detailed food and symptom diary to aid in identifying correlations between lifestyle habits and glucose levels. With the integration of these strategies and close follow-up, the team aims to achieve better glycemic control and mitigate the risk of further complications, setting the stage for the next phase of the patient's management journey.

Section 4

Three weeks after implementing the updated care plan, the patient returns for another assessment. During this visit, the team conducts a thorough evaluation to monitor the progression of diabetic complications and the response to recent interventions. The patient reports some improvement in neuropathic pain since starting gabapentin, yet continues to experience intermittent discomfort that impacts daily activities. Vital signs reveal a blood pressure reading of 142/88 mmHg, slightly elevated despite adherence to antihypertensive therapy, highlighting the need for further blood pressure management. The patient's weight remains stable, suggesting maintained adherence to dietary recommendations.

Repeat laboratory evaluations provide mixed insights. While there is a modest reduction in HbA1c to 8.2%, indicating a small improvement in glycemic control, it remains above the target range. This reinforces the importance of continued dietary adjustments and potentially increasing basal insulin dosage. The lipid profile shows a slight decrease in LDL cholesterol to 124 mg/dL, suggesting some positive response to intensified statin therapy. However, renal function tests show a concerning trend, with serum creatinine rising to 1.3 mg/dL and eGFR decreasing to 55 mL/min/1.73m². This progression of diabetic nephropathy necessitates a re-evaluation of the current ACE inhibitor dose and consideration of additional nephroprotective strategies.

The healthcare team acknowledges the complex interplay of these findings and discusses the potential need for further specialist consultation. Emphasizing the critical role of patient engagement, they reinforce education on medication adherence, dietary management, and the importance of regular blood glucose monitoring. Encouraging the patient to maintain their food and symptom diary, the team plans a follow-up in two weeks to closely track changes and adjust the treatment plan as necessary. The focus remains on achieving tighter glycemic and blood pressure control to prevent further complications and improve the patient's quality of life.

Section 5

Two weeks later, the patient returns for the scheduled follow-up, expressing continued concern about the persistent discomfort from neuropathy despite some initial relief with gabapentin. The patient now reports experiencing occasional episodes of dizziness and fatigue, particularly in the mornings, which prompts further investigation. Vital signs reveal a blood pressure of 138/85 mmHg, showing slight improvement but still requiring close management. During the physical examination, the healthcare provider notes mild bilateral pedal edema and diminished vibratory sensation in the feet, suggesting ongoing neuropathic changes.

The latest laboratory results reveal a further decline in renal function, with serum creatinine increasing to 1.5 mg/dL and eGFR dropping to 50 mL/min/1.73m². This trend indicates worsening diabetic nephropathy and raises concerns about potential fluid retention or electrolyte imbalances contributing to the patient's dizziness. Additionally, a urine microalbumin test has returned positive, confirming the presence of microalbuminuria and underscoring the need for more aggressive nephroprotective strategies. The HbA1c has slightly reduced to 8.0%, showing incremental progress in glycemic control, but still requiring further optimization.

In response to these developments, the healthcare team deliberates on adjusting the patient’s antihypertensive regimen, potentially incorporating a diuretic to address the edema and optimize blood pressure control. They also consider an endocrinology referral to evaluate the current insulin regimen and explore advanced treatment options to better manage glycemic levels. The team reinforces the importance of renal health monitoring and dietary modifications to reduce sodium intake, aiming to minimize fluid retention. They schedule a follow-up in one month, emphasizing the need for vigilant monitoring of symptoms and stressing the importance of maintaining a detailed log of blood glucose readings and daily symptoms to guide future treatment adjustments.